Linezolid (PNU-10766/PNU10766SS) in the Treatment of MRSA Infections in Patients Whose Conventional Therapy Has Failed, or Who Are Intolerant to Conventional Therapy; an Open-label, Multi-center Trial
Linezolid (PNU-10766/PNU10766SS) in the Treatment of MRSA Infections in Patients Whose Conventional Therapy Has Failed, or Who Are Intolerant to Conventional Therapy; an Open-label, Multi-center Trial
Use of linezolid in patients with methicillin-resistant Staphylococcus aureus infections in Japan
Inclusion Criteria:
Exclusion Criteria:
Onga-gun, Fukuoka 807-0051, Japan
Sappopro, Hokkaido 060-8648, Japan
Iruma-gun, Saitama 350-0495, Japan